Lunch Program: Emerging Microvascular Technologies to Improve STEMI Outcomes
Despite advances in reperfusion with primary stenting, STEMI outcomes have stagnated over the past 20 years, with 1 in 5 patients developing heart failure at 1 year. Hear global thought leaders discuss the rationale and science behind STEMI outcomes and what needs to be done to improve them. Learn about SSO2 Therapy and how it reduces infarct size in STEMI patients and hear about experiences with the therapy.
Fireside Chat / Panel Discussion
Timothy D. Henry, M.D., MSCAI, The Christ Hospital Health Network, Dayton, KY, Srihari S. Naidu, MD, FSCAI, Westchester Medical Center, New York, NY and Megha Prasad, M.D., NewYork-Presbyterian Columbia University Irving Medical Center, new york city, NY